The market for pharmaceuticals in Brazil has great potential. Yet Brazil's Health Authority is in conflict with the pharmaceutical industry over IP rights, and sales are suffering. Deborah Portilho and Rana Gosain of Daniel Advogados investigate
Unlock this article.
The content you are trying to view is exclusive to our subscribers.